Home › NDC Lookup › RxCUI directory › RxCUI 2716485

Sitagliptin 25 MG/ML Oral Solution — RxCUI 2716485

RxNorm drug concept · Semantic clinical drug
RxCUI 2716485 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2716485
Official nameSitagliptin 25 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assitagliptin 25 MG (as sitagliptin HCl) per 1 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sitagliptin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It isn't meant for type 1 diabetes.
  • Take it by mouth once a day, with or without food. If you use the Brynovin liquid, measure it with an oral syringe or dosing cup marked in mL. Follow your prescriber's instructions...
  • The most common are a stuffy nose or sore throat, upper respiratory infections and headache. If you also take insulin or a sulfonylurea, low blood sugar is more likely. Tell your d...
  • Call if you have severe stomach pain, swelling of your face or throat, a severe rash, blisters, severe joint pain, or symptoms of heart failure like shortness of breath or swelling...
📖 Read our full Sitagliptin guide →

🕸️ Concept Web — How Sitagliptin 25 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sitagliptin 25 MG/ML Oral Solution RxCUI 2716485

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sitagliptin 593411
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Brynovin 2716486
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sitagliptin Oral Solution 2716484
    • Sitagliptin Oral Liquid Product 2716483
    • Sitagliptin Oral Product 1159662
    • Sitagliptin Oral Solution [Brynovin] 2716490
    • Brynovin Oral Liquid Product 2716489
    • Brynovin Oral Product 2716488
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sitagliptin 25 MG/ML SCDC · 2716482
  • Sitagliptin Oral Solution SCDF · 2716484
  • Sitagliptin Oral Liquid Product SCDG · 2716483
  • Sitagliptin Oral Product SCDG · 1159662

Brand-Name Concepts

  • Sitagliptin 25 MG/ML Oral Solution [Brynovin] SBD · 2716491
  • Sitagliptin 25 MG/ML [Brynovin] SBDC · 2716487
  • Sitagliptin Oral Solution [Brynovin] SBDF · 2716490
  • Brynovin Oral Liquid Product SBDG · 2716489
  • Brynovin Oral Product SBDG · 2716488
  • Brynovin BN · 2716486

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2716485 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24338-0017-01 1 BOTTLE in 1 CARTON (24338-017-01) / 120 mL in 1 BOTTLE BRYNOVIN Azurity Pharmaceuticals, Inc. 2025-04-01
Observed labelers: Azurity Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.